De novo acute hepatitis B infection in a previously vaccinated liver transplant recipient due to a strain of HBV with a Met 133 Thr mutation in the ″a″ determinant

Liver

Volumn 20, Issue 5, 2000, Pages 411-414

  Yoshida, Eric M ^a,c   Ramji, Alnoor ^a   Erb, Siegfried R ^a   Davis, Jennifer E ^a   Steinbrecher, Urs P ^a   Sherlock, Christopher H ^a   Scudamore, Charles H ^a   Chung, Stephen W ^a   Williams, Mark ^b   Gutfreund, Klaus S ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

De novo; Hepatitis B; Liver; Mutant; Surface antigen; Transplantation; Vaccination

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMINO ACID; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; GLUCOCORTICOID; HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; METHIONINE; THREONINE; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CASE STUDY; CAUCASIAN; CLINICAL FEATURE; DNA HYBRIDIZATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER NECROSIS; LIVER TRANSPLANTATION; MULTIPLE ORGAN FAILURE; NONHUMAN; ORGAN DONOR; PRIMARY BILIARY CIRRHOSIS; RECIPIENT; REVACCINATION; SEPSIS; SERODIAGNOSIS; TISSUE DEGENERATION; VIRUS MUTATION; VIRUS STRAIN;

ACUTE DISEASE; ADULT; AMINO ACID SUBSTITUTION; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATOCYTES; HISTOCYTOCHEMISTRY; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MUTATION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TISSUE DONORS; VACCINATION;

EID: 0033820063     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2000.020005411.x     Document Type: Article

References (14)

1. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
2. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen
3. Liver transplantation and de novo hepatitis B infection
4. Hepatitis B virus replication patterns after orthotopic liver transplantation: De novo versus recurrent infection
5. ″Occult″ hepatitis B virus as source of infection in liver transplant recipients
6. Severe clinical course of de novo hepatitis B infection after liver transplantation
7. Viral serology and detection
8. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis
9. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
10. Vaccine-induced escape mutant of hepatitis B virus
11. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclohal HBsAg ELISA
12. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore
13. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays
14. Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to the hepatitis B virus with the use of lamivudine